LONDON, June 25, 2025 /CNW/ -- The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) is one of the best mid cap growth stocks to invest in now. Earlier on June 5 ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx ...

John Driskell Hopkins is a founding member of the Grammy-winning Zac Brown Band. In December 2021, he was diagnosed with the ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three ...

The experimental ALS treatment usnoflast exhibited promising signs of slowed functional decline and improved breathing in a ...

The adult neurodegenerative disorder amyotrophic lateral sclerosis (ALS) is unmistakeable from clinical descriptions now more than a century old.1 Neither the site of symptom onset in ALS2 nor pattern ...

Living near cyanobacterial blooms shortens survival in amyotrophic lateral sclerosis * Exposure to neurotoxic water sources ...

Brainstorm Cell Therapeutics plans to launch a Phase 3b trial to test NurOwn against a placebo in about 200 people with mild to moderate ALS.